AS 5370

Drug Profile

AS 5370

Alternative Names: AS-5370; DAT-537

Latest Information Update: 20 Jun 2000

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Dainippon Pharmaceutical
  • Class Antiemetics
  • Mechanism of Action Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Migraine; Nausea and vomiting; Schizophrenia

Most Recent Events

  • 20 Jun 2000 Discontinued-Preclinical for Emesis in Japan (Unknown route)
  • 20 Jun 2000 Discontinued-Preclinical for Migraine in Japan (Unknown route)
  • 20 Jun 2000 Discontinued-Preclinical for Schizophrenia in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top